Rubicon Research is an IP led, specialty pharmaceutical company focused on our mission to provide innovative yet affordable patient-centered products and solutions so as to address unmet needs around the world. We leverage our proprietary technologies and specialized formulation development skills to provide solutions to complex delivery challenges; enabling better patient outcomes.
Our portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, ophthalmic, injectable, topical, drug device combinations and fixed-dose combinations. We hold more than 50 issued patents in drug delivery technologies, and have launched over 64 SKUs, with over 1.3+ billion extended units sold in the US in 2020. In the pipeline are 10+ approvals and launches (across oral solids and ophthalmic formulations) slated for 2021. Additionally, there are more than 130 products in development and 22 filed products under review with the US FDA.
Vacancy Details
Check out the image for more details. Send your resumes to priyanka.patil@rubicon.co.in
The CSC is a strategic cornerstone of the National e-Governance Plan (NeGP), approved by the…
As a data services company clickworker uses its own trusted platform to set up your data…
To submit your Enumeration Form online (e.g., during the Special Intensive Revision - SIR process),…
AP 10th Class Results 2026 Live Updates: The Board of Secondary Education Andhra Pradesh (BSEAP) is…
What is AP POLYCET 2026? The Andhra Pradesh Polytechnic Common Entrance Test (AP POLYCET) is…
The Income Tax Act, 2025 marks a historic milestone in India’s direct taxation framework by…